Click here to download the agreement
Prepared for: __________________________________
Prepared by: __________________________________
Agreement: ForsLean® Version: 40914.2
Patents: US 5,804,596, EP0977564, CA228156
ForsLean® supplied by Sabinsa is a patented ingredient designed for the Nutraceutical and Functional Foods market. Due to the unique properties of this ingredient and the language used in the patents, the Customer agrees to the following criteria, terms and conditions which Sabinsa and the Customer deem necessary to assure the protection of the intellectual property rights, identity and integrity of ForsLean® in the marketplace.
With respect to any product or formulation containing ForsLean®, the Customer agrees:
This agreement applies to all products containing ForsLean® whether manufactured, sold, distributed or marketed by the Customer and/or others. Other than for use in manufacturing the Customer’s own product, the Customer shall not resell or supply ForsLean® in the bulk raw material form, either directly or indirectly, to any third party. Sabinsa will supply only to the manufacturer. If the Customer is not the manufacturer, the Customer shall inform Sabinsa of the name and address of the customer’s manufacturer. If the Customer is a contract manufacturer, and supplies, but does not own or control, the finished product, the contract manufacturer shall inform its Customer to the terms and conditions of this agreement. A license agreement must be executed by each of the contract manufacturers Customers and Sabinsa
Additionally, the Customer shall provide Sabinsa with a current or known future list of products containing ForsLean®. Customer must update any additions and deletions to this list annually.
Use of ForsLean® requires that the provisions of this agreement be understood and accepted by all those who use and market it. Sabinsa may refuse to supply or sell ForsLean® to any person or entity who fails to honor this agreement; however, Customer will be given reasonable time to sell through inventory after receipt of written notification detailing the reasons for terminating this agreement. Sabinsa may also pursue any and all legal rights, remedies and recourse in the event of a breach of this Agreement.
This Agreement is binding upon the Customer, its successors and assigns. This Agreement shall be governed by, enforced under and interpreted in accordance with the laws of The State of New Jersey, United States of America, to which jurisdiction the parties, hereby, submit.
The following product(s) are submitted by the Customer for approval to include the ingredient ForsLean®, according to the terms and conditions of the Trademark License Agreement. Please indicate the brand and product trade name.
Name of Marketing Company ________________________________________________________________________
Name and address of Manufacturing Company (if different from Marketing Company):
ACCEPTANCE OF AGREEMENT BY AUTHORIZED REPRESENTATIVE:
Company / Customer _______________________________________________________________
Name / Title (please print) __________________________________________________________
Signature ________________________________________ Date ____________________________
Sabinsa Wins Again: Federal Court Denies Creative Compounds Motion
Listen to a brief video on ForsLean®
View past and recent advertisements
Innovative Ingredients Paper Weight loss approach
Sabinsa calls to readers' attention that some of the products, protocols and uses of the products described here in are or may be subject to various restrictions or limitations because of patents, exclusive or nonexclusive licenses, confidentiality agreements and other intellectual property or equivalent rights. Readers are advised to make an early and thorough investigation and inquiry into any product, protocol or use in which they may be interested, to see if any such rights might be applicable. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.